Tecentriq 1 875 mg solution for injection
*Company:
Roche Registration GmbHStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 22 March 2024
File name
TCN-SmPC-1875mg-220224.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
File name
Tecentriq Patient Card IE Version 26.1.3 (1).pdf
Reasons for updating
- Add New Doc
Updated on 29 February 2024
File name
TCN-PIL-1875mg-22feb2024.pdf
Reasons for updating
- Change to improve clarity and readability
Updated on 29 February 2024
File name
TCN-SmPC-1875mg-22feb2024.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 27 February 2024
File name
TCN-1875mg PIL 22Feb24.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
Updated on 27 February 2024
File name
TCN-1875mg SmPC 22Feb24.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 17 January 2024
File name
IRL-TCN-1875mg-SmPC.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 17 January 2024
File name
IRL-TCN-1875mg_PIL.pdf
Reasons for updating
- New PIL for new product